Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
Hossam El Benawi, Senior Clinical Research Fellow of Cardiovascular Medicine at Mayo Clinic, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:
“How do we predict recurrence post Left Ventricular Thrombus ( LVT ) resoultion?
Echo at the time of LVT resolution preditctive than the time of Diagnosis
After LVT resolution, patient with left ventricular aneurysm (LVA) remained at high risk of recurrence regardless of anticoagulation status, with recurrence rates approaching 50–70% (Figure 1).
Stopping oral anticoagulation (OAC) after LVT resolution increased recurrence risk even in patients without LVA, rising to 19%(Figure 2).
Risk stratification combining LVA status and OAC use revealed a clear gradient of recurrence risk (Figure 3):
Without LVA and receiving OAC: 5/113 (4%)
Without LVA and not receiving OAC: 22/116 (19%)
With LVA and receiving OAC: 4/13 (31%)
With LVA and not receiving OAC: 5/10 (50%)
Highest recurrence: Patients with LVA who were not receiving OAC
Lowest recurrence: Patients without LVA who were receiving OAC
The key question:
If recurrence risk remains elevated across all groups, who can truly stop OAC after LVT resolution?
Stay tunned for Mayo LVT part 3″
Title: Clinical and Echocardiographic Factors Associated With Left Ventricular Thrombus Recurrence
Authors: Kirsten M. Lipps, Hossam Elbenawi, Samuel Heller Jr., Robert D. McBane, Waldemar E. Wysokinski, Ana I. Casanegra, Stanislav Henkin, Thom W. Rooke, Paul W. Wennberg, David A. Liedl, Raymond C. Shields, Damon E. Houghton
Other posts featuring Hossam El Benawi on Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda